The browser you are using is not supported by this website. All versions of Internet Explorer are no longer supported, either by us or Microsoft (read more here: https://www.microsoft.com/en-us/microsoft-365/windows/end-of-ie-support).

Please use a modern browser to fully experience our website, such as the newest versions of Edge, Chrome, Firefox or Safari etc.

Development of Gene Therapy for Hematopoietic Stem Cells using Lentiviral Vectors

På svenska

Author

Summary, in English

Hematopoietic stem cells are an ideal target for genetic manipulation for the purpose of curing hematological disorders as they have the ability to develop into all blood lineages and to self-renew. In this study we demonstrate that lentiviral vectors, based on HIV-1, can efficiently transfer genes into human hematopoietic progenitor and stem cells as assessed following stem cell transplantation in immune compromised mice. High efficiency transduction of repopulating cells was achieved in both primary (48±23%, n=6) and secondary transplant recipients (64±13%). These results demonstrate the ability of lentiviral vectors to efficiently transduce human pluripotent candidate stem cells. Modifications to the vector design were performed to optimize the vector for high-level transgene expression in the progeny of the repopulating cells. Eight-fold higher expression levels were achieved in mice in both the lymphoid and myeloid progeny cells compared to the original lentiviral vectors. We also analyzed the vector copy number in the bone marrow cells by semi-quantitative PCR. To our surprise we found that on average there were multiple vector copies integrated per transduced cell (5.6±3.3 n=12). While the multiple vector copy integration into stem cells is efficient in terms of transduction and expression, it may increase the risk for insertional mutagenesis. Transduction of murine embryonic stem cells was performed to study transgene expression throughout in vitro differentiation to hematopoietic cells. In addition, we optimized the conditions for gene transfer into murine hematopoietic progenitors in order to be able to test hematopoietic stem cell gene therapy in animal models of human disease. These studies demonstrate the ability of lentiviral vectors to efficiently transduce human hematopoietic stem cells, and advance lentiviral vectors as a tool for the treatment of hematological disorders.

Publishing year

2002

Language

English

Document type

Dissertation

Publisher

Margareta Ingloff (Secretary) Dept. of Molecular Medicine & Gene Therapy, BMC A12, SE-22184 Lund, Sweden, tel. +46 46 222-0575.,

Topic

  • Neurosciences

Keywords

  • embryonic stem cell
  • Hematopoietic stem cell
  • lentiviral vector
  • transduction efficiency
  • transgene expression
  • multiple vector copy integration
  • insertional mutagenesis
  • NOD/SCID mouse
  • cytogenetics
  • Genetics
  • extracellulära vätskor
  • extracellular fluids
  • cytogenetik
  • Genetik
  • Haematology
  • Hematologi

Status

Published

Supervisor

  • [unknown] [unknown]

ISBN/ISSN/Other

  • ISBN: 91-628-5337-2

Defence date

22 October 2002

Defence time

13:00

Defence place

Segerfalksalen auditorium, Wallenberg Neurocentrum, Sölvegatan 17, Lund, Sweden

Opponent

  • R. Keith Humphries (Prof, MD, PhD)